0000950170-23-060286.txt : 20231107 0000950170-23-060286.hdr.sgml : 20231107 20231107161833 ACCESSION NUMBER: 0000950170-23-060286 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231031 FILED AS OF DATE: 20231107 DATE AS OF CHANGE: 20231107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cafico Trust Co Ltd CENTRAL INDEX KEY: 0001685917 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41837 FILM NUMBER: 231384209 BUSINESS ADDRESS: STREET 1: PALMERSTOWN HOUSE, FENIAN STREET CITY: DUBLIN STATE: L2 ZIP: DUBLIN 2 BUSINESS PHONE: 0035319058020 MAIL ADDRESS: STREET 1: PALMERSTOWN HOUSE, FENIAN STREET CITY: DUBLIN STATE: L2 ZIP: DUBLIN 2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mural Oncology plc CENTRAL INDEX KEY: 0001971543 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 EARLSFORT TERRACE CITY: DUBLIN 2 STATE: L2 ZIP: D02 T380 BUSINESS PHONE: 353 1 905 8020 MAIL ADDRESS: STREET 1: 10 EARLSFORT TERRACE CITY: DUBLIN 2 STATE: L2 ZIP: D02 T380 FORMER COMPANY: FORMER CONFORMED NAME: Mural Oncology Ltd DATE OF NAME CHANGE: 20230403 FORMER COMPANY: FORMER CONFORMED NAME: Pistachiovale Ltd DATE OF NAME CHANGE: 20230329 3 1 ownership.xml 3 X0206 3 2023-10-31 0 0001971543 Mural Oncology plc MURA 0001685917 Cafico Trust Co Ltd PALMERSTOWN HOUSE, FENIAN STREET DUBLIN L2 DUBLIN 2 IRELAND false false true false Ordinary Shares, nominal value $1.00 per share 2 D Euro Deferred Shares, nominal value 1.00 Euro per share 25000 D Preferred Share, nominal value $0.01 per share 1 D The ordinary shares of Mural Oncology plc ("Mural"), nominal value $1.00 per share, beneficially owned by Cafico Trust Company Limited, constitute 100% of the ordinary shares of Mural. As of the date of this report, Alkermes plc ("Alkermes") has announced its intention to separate its oncology business from the rest of Alkermes by means of a declaration of a dividend in specie, to be effected by the transfer of the oncology business from Alkermes to Mural and the issuance by Mural of ordinary shares to Alkermes shareholders. In connection with the separation of the oncology business, Cafico Trust Company Limited also owns (i) 25,000 Euro deferred shares, nominal value 1.00 Euro per share, and (ii) one preferred share, nominal value $0.01, of Mural. /s/ Mairead Lyons 2023-11-07